Douglas Altman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Activities & Behaviors

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Thorpe Kevin E; Zwarenstein Merrick; Oxman Andrew D; Treweek Shaun; Furberg Curt D; Altman Douglas G; Tunis Sean; Bergel Eduardo; Harvey Ian; Magid David J; Chalkidou Kalipso
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
Riley R D; Sauerbrei W; Altman D G
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
Altman Douglas G
Prognostic models: a methodological framework and review of models for breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Douglas Altman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Thorpe Kevin E; Zwarenstein Merrick; Oxman Andrew D; Treweek Shaun; Furberg Curt D; Altman Douglas G; Tunis Sean; Bergel Eduardo; Harvey Ian; Magid David J; Chalkidou Kalipso
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;180(10):E47-57.
2009: Riley R D; Sauerbrei W; Altman D G
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
British journal of cancer 2009;100(8):1219-29.
2009: Altman Douglas G
Prognostic models: a methodological framework and review of models for breast cancer.
Cancer investigation 2009;27(3):235-43.
2009: Vandenbroucke Jan P; Von Elm Erik; Altman Douglas G; Gøtzsche Peter C; Mulrow Cynthia D; Pocock Stuart J; Poole Charles; Schlesselman James J; Egger Matthias;
[Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]
Gaceta sanitaria / S.E.S.P.A.S 2009;23(2):158.
2009: Altman Douglas G; Vergouwe Yvonne; Royston Patrick; Moons Karel G M
Prognosis and prognostic research: validating a prognostic model.
BMJ (Clinical research ed.) 2009;338():b605.
2009: Altman Douglas G; Bland J Martin
Parametric v non-parametric methods for data analysis.
BMJ (Clinical research ed.) 2009;338():a3167.
2008: von Elm Erik; Altman Douglas G
Reporting guidelines: looking back from the future.
Chest 2008;134(4):682-4.
2008: Stocken D D; Hassan A B; Altman D G; Billingham L J; Bramhall S R; Johnson P J; Freemantle N
Modelling prognostic factors in advanced pancreatic cancer.
British journal of cancer 2008;99(6):883-93.
2008: Ramasamy Adaikalavan; Mondry Adrian; Holmes Chris C; Altman Douglas G
Key issues in conducting a meta-analysis of gene expression microarray datasets.
PLoS medicine 2008;5(9):e184.
2008: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]
Revista española de salud pública 2008;82(3):251-9.
2008: Punwani S; Halligan S; Irving P; Bloom S; Bungay A; Greenhalgh R; Godbold J; Taylor S A; Altman D G
Measurement of colonic polyps by radiologists and endoscopists: who is most accurate?
European radiology 2008;18(5):874-81.
2008: Altman Douglas G; Simera Iveta; Hoey John; Moher David; Schulz Ken
EQUATOR: reporting guidelines for health research.
Lancet 2008;371(9619):1149-50.
2008: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Journal of clinical epidemiology 2008;61(4):344-9.
2008: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]
Gaceta sanitaria / S.E.S.P.A.S 2008;22(2):144-50.
2008: Robinson Charlotte; Halligan Steve; Taylor Stuart A; Mallett Susan; Altman Douglas G
CT colonography: a systematic review of standard of reporting for studies of computer-aided detection.
Radiology 2008;246(2):426-33.
2008: Hopewell Sally; Altman Douglas G; Moher David; Schulz Kenneth F
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.
Trials 2008;9():20.
2007: Vandenbroucke Jan P; von Elm Erik; Altman Douglas G; Gøtzsche Peter C; Mulrow Cynthia D; Pocock Stuart J; Poole Charles; Schlesselman James J; Egger Matthias;
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
Epidemiology (Cambridge, Mass.) 2007;18(6):805-35.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Epidemiology (Cambridge, Mass.) 2007;18(6):800-4.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Bulletin of the World Health Organization 2007;85(11):867-72.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Lancet 2007;370(9596):1453-7.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Preventive medicine 2007;45(4):247-51.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
BMJ (Clinical research ed.) 2007;335(7624):806-8.
2007: Vandenbroucke Jan P; von Elm Erik; Altman Douglas G; Gøtzsche Peter C; Mulrow Cynthia D; Pocock Stuart J; Poole Charles; Schlesselman James J; Egger Matthias;
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
PLoS medicine 2007;4(10):e297.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
PLoS medicine 2007;4(10):e296.
2007: von Elm Erik; Altman Douglas G; Egger Matthias; Pocock Stuart J; Gøtzsche Peter C; Vandenbroucke Jan P;
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Annals of internal medicine 2007;147(8):573-7.
2007: Vandenbroucke Jan P; von Elm Erik; Altman Douglas G; Gøtzsche Peter C; Mulrow Cynthia D; Pocock Stuart J; Poole Charles; Schlesselman James J; Egger Matthias;
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
Annals of internal medicine 2007;147(8):W163-94.
2007: Pildal J; Hróbjartsson A; Jørgensen K J; Hilden J; Altman D G; Gøtzsche P C
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
International journal of epidemiology 2007;36(4):847-57.
2007: Trivella Marialena; Pezzella Francesco; Pastorino Ugo; Harris Adrian L; Altman Douglas G;
Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.
The lancet oncology 2007;8(6):488-99.
2007: Halligan Steve; Altman Douglas G
Evidence-based practice in radiology: steps 3 and 4--appraise and apply systematic reviews and meta-analyses.
Radiology 2007;243(1):13-27.
2007: Altman Douglas G; Bland J Martin
Missing data.
BMJ (Clinical research ed.) 2007;334(7590):424.
2007: Gøtzsche Peter C; Hróbjartsson Asbjørn; Johansen Helle Krogh; Haahr Mette T; Altman Douglas G; Chan An-Wen
Ghost authorship in industry-initiated randomised trials.
PLoS medicine 2007;4(1):e19.
2006: Halligan Steve; Altman Douglas G; Mallett Susan; Taylor Stuart A; Burling David; Roddie Mary; Honeyfield Lesley; McQuillan Justine; Amin Hamdan; Dehmeshki Jamshid
Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detection.
Gastroenterology 2006;131(6):1690-9.
2006: Burton Andrea; Altman Douglas G; Royston Patrick; Holder Roger L
The design of simulation studies in medical statistics.
Statistics in medicine 2006;25(24):4279-92.
2006: Pyper Cecilia; Bromhall Lise; Dummett Sarah; Altman Douglas G; Brownbill Pat; Murphy Michael
The Oxford Conception Study design and recruitment experience.
Paediatric and perinatal epidemiology 2006;20 Suppl 1():51-9.
2006: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
REporting recommendations for tumor MARKer prognostic studies (REMARK).
Breast cancer research and treatment 2006;100(2):229-35.
2006: Mallett Susan; Deeks Jonathan J; Halligan Steve; Hopewell Sally; Cornelius Victoria; Altman Douglas G
Systematic reviews of diagnostic tests in cancer: review of methods and reporting.
BMJ (Clinical research ed.) 2006;333(7565):413.
2006: McShane L M; Altman D G; Sauerbrei W; Taube S E; Gion M; Clark G M;
Reporting recommendations for tumor marker prognostic studies (remark).
Experimental oncology 2006;28(2):99-105.
2006: Gøtzsche Peter C; Hróbjartsson Asbjørn; Johansen Helle Krogh; Haahr Mette T; Altman Douglas G; Chan An-Wen
[Constraints on publication rights in industry-initiated clinical trials--secondary publication]
Ugeskrift for laeger 2006;168(25):2467-9.
2006: Burling David; Halligan Steve; Taylor Stuart; Brennand Duncan J; Altman Douglas G; Bassett Paul; Atkin Wendy; Bartram Clive I
Polyp measurement using CT colonography: agreement with colonoscopy and effect of viewing conditions on interobserver and intraobserver agreement.
AJR. American journal of roentgenology 2006;186(6):1597-604.
2006: Altman Douglas G; Royston Patrick
The cost of dichotomising continuous variables.
BMJ (Clinical research ed.) 2006;332(7549):1080.
2006: Gøtzsche Peter C; Hróbjartsson Asbjørn; Johansen Helle Krogh; Haahr Mette T; Altman Douglas G; Chan An-Wen
Constraints on publication rights in industry-initiated clinical trials.
JAMA : the journal of the American Medical Association 2006;295(14):1645-6.
2006: Royston Patrick; Altman Douglas G; Sauerbrei Willi
Dichotomizing continuous predictors in multiple regression: a bad idea.
Statistics in medicine 2006;25(1):127-41.
2006: Liu Joseph; Wyatt Jeremy C; Altman Douglas G
Decision tools in health care: focus on the problem, not the solution.
BMC medical informatics and decision making 2006;6():4.
2005: Halligan Steve; Altman Douglas G; Taylor Stuart A; Mallett Susan; Deeks Jonathan J; Bartram Clive I; Atkin Wendy
CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting.
Radiology 2005;237(3):893-904.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
Reporting recommendations for tumor marker prognostic studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9067-72.
2005: von Elm Erik; Altman Douglas G; Pocock Stuart; Vandenbroucke Jan P; Egger Matthias
Re: "quality of reporting of observational longitudinal research".
American journal of epidemiology 2005;162(10):1032-3; author reply 1033.
2005: Altman Douglas G; Bland J Martin
Standard deviations and standard errors.
BMJ (Clinical research ed.) 2005;331(7521):903.
2005: Altman Douglas G; Riley Richard D
Primer: an evidence-based approach to prognostic markers.
Nature clinical practice. Oncology 2005;2(9):466-72.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
REporting recommendations for tumor MARKer prognostic studies (REMARK).
Nature clinical practice. Urology 2005;2(8):416-22.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
REporting recommendations for tumor MARKer prognostic studies (REMARK).
Nature clinical practice. Oncology 2005;2(8):416-22.
2005: Hróbjartsson Asbjørn; Chan An-Wen; Haahr Mette T; Gøtzsche Peter C; Altman Douglas G
[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports]
Ugeskrift for laeger 2005;167(34):3189-91.
2005: McShane L M; Altman D G; Sauerbrei W; Taube S E; Gion M; Clark G M;
REporting recommendations for tumour MARKer prognostic studies (REMARK).
British journal of cancer 2005;93(4):387-91.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
Reporting recommendations for tumor marker prognostic studies (REMARK).
Journal of the National Cancer Institute 2005;97(16):1180-4.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi; Taube Sheila E; Gion Massimo; Clark Gary M;
REporting recommendations for tumour MARKer prognostic studies (REMARK).
European journal of cancer (Oxford, England : 1990) 2005;41(12):1690-6.
2005: McShane Lisa M; Altman Douglas G; Sauerbrei Willi
Identification of clinically useful cancer prognostic factors: what are we missing?
Journal of the National Cancer Institute 2005;97(14):1023-5.
2005: Glenny A M; Altman D G; Song F; Sakarovitch C; Deeks J J; D'Amico R; Bradburn M; Eastwood A J;
Indirect comparisons of competing interventions.
Health technology assessment (Winchester, England) 2005;9(26):1-134, iii-iv.
2005: Pildal Julie; Chan An-Wen; Hróbjartsson Asbjørn; Forfang Elisabeth; Altman Douglas G; Gøtzsche Peter C
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.
BMJ (Clinical research ed.) 2005;330(7499):1049.
2005: Altman Douglas G; Bland J Martin
Treatment allocation by minimisation.
BMJ (Clinical research ed.) 2005;330(7495):843.
2005: Chan An-Wen; Altman Douglas G
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.
BMJ (Clinical research ed.) 2005;330(7494):753.
2005: Chan An-Wen; Altman Douglas G
Epidemiology and reporting of randomised trials published in PubMed journals.
Lancet 2005;365(9465):1159-62.
2005: Grant A M; Altman D G; Babiker A B; Campbell M K; Clemens F J; Darbyshire J H; Elbourne D R; McLeer S K; Parmar M K B; Pocock S J; Spiegelhalter D J; Sydes M R; Walker A E; Wallace S A;
Issues in data monitoring and interim analysis of trials.
Health technology assessment (Winchester, England) 2005;9(7):1-238, iii-iv.
2004: Altman Douglas G
Improving design and analysis of research: lessons from clinical research.
Alternatives to laboratory animals : ATLA 2004;32 Suppl 2():31-9.
2004: Burton A; Altman D G
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines.
British journal of cancer 2004;91(1):4-8.
2004: Chan An-Wen; Hróbjartsson Asbjørn; Haahr Mette T; Gøtzsche Peter C; Altman Douglas G
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
JAMA : the journal of the American Medical Association 2004;291(20):2457-65.
2004: Campbell Marion K; Elbourne Diana R; Altman Douglas G;
CONSORT statement: extension to cluster randomised trials.
BMJ (Clinical research ed.) 2004;328(7441):702-8.
2004: Sydes Matthew R; Spiegelhalter David J; Altman Douglas G; Babiker Abdel B; Parmar Mahesh K B;
Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials.
Clinical trials (London, England) 2004;1(1):60-79.
2004: Sydes Matthew R; Altman Douglas G; Babiker Abdel B; Parmar Mahesh K B; Spiegelhalter David J;
Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
Clinical trials (London, England) 2004;1(1):48-59.
2003: Clark T G; Bradburn M J; Love S B; Altman D G
Survival analysis part IV: further concepts and methods in survival analysis.
British journal of cancer 2003;89(5):781-6.
2003: Bradburn M J; Clark T G; Love S B; Altman D G
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.
British journal of cancer 2003;89(4):605-11.
2003: Bradburn M J; Clark T G; Love S B; Altman D G
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.
British journal of cancer 2003;89(3):431-6.
2003: Clark T G; Bradburn M J; Love S B; Altman D G
Survival analysis part I: basic concepts and first analyses.
British journal of cancer 2003;89(2):232-8.
2003: Song Fujian; Altman Douglas G; Glenny Anne-Marie; Deeks Jonathan J
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.
BMJ (Clinical research ed.) 2003;326(7387):472.
2003: Clark Taane G; Altman Douglas G
Developing a prognostic model in the presence of missing data: an ovarian cancer case study.
Journal of clinical epidemiology 2003;56(1):28-37.
2003: Altman Douglas G; Bland J Martin
Interaction revisited: the difference between two estimates.
BMJ (Clinical research ed.) 2003;326(7382):219.
2003: Deeks J J; Dinnes J; D'Amico R; Sowden A J; Sakarovitch C; Song F; Petticrew M; Altman D G;
Evaluating non-randomised intervention studies.
Health technology assessment (Winchester, England) 2003;7(27):iii-x, 1-173.
2002: Altman Douglas G
Commentary: Systematic reviewers face challenges from varied study designs.
BMJ (Clinical research ed.) 2002;325(7362):461.
2002: Curtin François; Elbourne Diana; Altman Douglas G
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
Statistics in medicine 2002;21(15):2161-73.
2002: Curtin François; Elbourne Diana; Altman Douglas G
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
Statistics in medicine 2002;21(15):2145-59.
2002: Curtin François; Altman Douglas G; Elbourne Diana
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
Statistics in medicine 2002;21(15):2131-44.
2002: Altman Douglas G
Poor-quality medical research: what can journals do?
JAMA : the journal of the American Medical Association 2002;287(21):2765-7.
2002: Pocock Stuart J; Clayton Tim C; Altman Douglas G
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.
Lancet 2002;359(9318):1686-9.
2002: Clark Taane G; Altman Douglas G; De Stavola Bianca L
Quantification of the completeness of follow-up.
Lancet 2002;359(9314):1309-10.
2002: Bland J Martin; Altman Douglas G
Statistics Notes: Validating scales and indexes.
BMJ (Clinical research ed.) 2002;324(7337):606-7.
2002: Elbourne Diana R; Altman Douglas G; Higgins Julian P T; Curtin Francois; Worthington Helen V; Vail Andy
Meta-analyses involving cross-over trials: methodological issues.
International journal of epidemiology 2002;31(1):140-9.
2002: Altman Douglas G; Deeks Jonathan J
Meta-analysis, Simpson's paradox, and the number needed to treat.
BMC medical research methodology 2002;2():3.
2001: Altman D G; Schulz K F
Statistics notes: Concealing treatment allocation in randomised trials.
BMJ (Clinical research ed.) 2001;323(7310):446-7.
2001: Altman D G
Systematic reviews of evaluations of prognostic variables.
BMJ (Clinical research ed.) 2001;323(7306):224-8.
2001: Jüni P; Altman D G; Egger M
Systematic reviews in health care: Assessing the quality of controlled clinical trials.
BMJ (Clinical research ed.) 2001;323(7303):42-6.
2000: Altman D G
Statistics in medical journals: some recent trends.
Statistics in medicine 2000;19(23):3275-89.
2000: Bland J M; Altman D G
Statistics notes. The odds ratio.
BMJ (Clinical research ed.) 2000;320(7247):1468.
2000: Altman D G; Royston P
What do we mean by validating a prognostic model?
Statistics in medicine 2000;19(4):453-73.
1999: Altman D G; Bland J M
How to randomise.
BMJ (Clinical research ed.) 1999;319(7211):703-4.
1999: Altman D G; Bland J M
Statistics notes: variables and parameters.
BMJ (Clinical research ed.) 1999;318(7199):1667.
1999: Wyatt J C; Paterson-Brown S; Fisk N M; Johanson R; Altman D G; Bradburn M
Randomised trials useful to find best methods of enhancing clinical practice.
BMJ (Clinical research ed.) 1999;318(7194):1353.
1999: Altman D G; Bland J M
Statistics notes. Treatment allocation in controlled trials: why randomise?
BMJ (Clinical research ed.) 1999;318(7192):1209.
1998: Altman D G
Statistical reviewing for medical journals.
Statistics in medicine 1998;17(23):2661-74.
1998: Bland J M; Altman D G
Survival probabilities (the Kaplan-Meier method).
BMJ (Clinical research ed.) 1998;317(7172):1572.
1998: Altman D G
Confidence intervals for the number needed to treat.
BMJ (Clinical research ed.) 1998;317(7168):1309-12.
1998: Bland J M; Altman D G
Bayesians and frequentists.
BMJ (Clinical research ed.) 1998;317(7166):1151-60.
1998: Wyatt J C; Paterson-Brown S; Johanson R; Altman D G; Bradburn M J; Fisk N M
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units.
BMJ (Clinical research ed.) 1998;317(7165):1041-6.
1998: Altman D G; Bland J M
Time to event (survival) data.
BMJ (Clinical research ed.) 1998;317(7156):468-9.
1998: Altman D G; Bland J M
Generalisation and extrapolation.
BMJ (Clinical research ed.) 1998;317(7155):409-10.
1998: Bradburn M J; Altman D G; Smith P; Fentiman I S; Rubens R D
Time trends in breast cancer survival: experience in a single centre, 1975-89.
British journal of cancer 1998;77(11):1944-9.
1997: Altman D G; Bland J M
Statistics notes. Units of analysis.
BMJ (Clinical research ed.) 1997;314(7098):1874.
1997: Bland J M; Altman D G
Cronbach's alpha.
BMJ (Clinical research ed.) 1997;314(7080):572.
1996: Altman D G; Bland J M
Detecting skewness from summary information.
BMJ (Clinical research ed.) 1996;313(7066):1200.
1996: Bland J M; Altman D G
Measurement error.
BMJ (Clinical research ed.) 1996;313(7059):744.
1996: Bland J M; Altman D G
Measurement error proportional to the mean.
BMJ (Clinical research ed.) 1996;313(7049):106.
1996: Bland J M; Altman D G
Measurement error and correlation coefficients.
BMJ (Clinical research ed.) 1996;313(7048):41-2.
1996: Bland J M; Altman D G
Measurement error.
BMJ (Clinical research ed.) 1996;312(7047):1654.
1996: Bland J M; Altman D G
The use of transformation when comparing two means.
BMJ (Clinical research ed.) 1996;312(7039):1153.
1996: Bland J M; Altman D G
Transformations, means, and confidence intervals.
BMJ (Clinical research ed.) 1996;312(7038):1079.
1996: Bland J M; Altman D G
Transforming data.
BMJ (Clinical research ed.) 1996;312(7033):770.
1995: Bland J M; Altman D G
Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects.
BMJ (Clinical research ed.) 1995;310(6980):633.
1995: Bland J M; Altman D G
Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects.
BMJ (Clinical research ed.) 1995;310(6977):446.
1995: Bland J M; Altman D G
Multiple significance tests: the Bonferroni method.
BMJ (Clinical research ed.) 1995;310(6973):170.
1995: Bland J M; Altman D G
Comparing two methods of clinical measurement: a personal history.
International journal of epidemiology 1995;24 Suppl 1():S7-14.
1994: Bland J M; Altman D G
Matching.
BMJ (Clinical research ed.) 1994;309(6962):1128.
1994: Bland J M; Altman D G
Some examples of regression towards the mean.
BMJ (Clinical research ed.) 1994;309(6957):780.
1994: Bland J M; Altman D G
One and two sided tests of significance.
BMJ (Clinical research ed.) 1994;309(6949):248.
1994: Bland J M; Altman D G
Regression towards the mean.
BMJ (Clinical research ed.) 1994;308(6942):1499.
1994: Bland J M; Altman D G
Correlation, regression, and repeated data.
BMJ (Clinical research ed.) 1994;308(6933):896.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Douglas Altman

Research Profile (preview)

Concepts & Ideas

Activities & Behaviors

Procedures

Disorders

Chemicals & Drugs

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Douglas Altman (preview)

All Publications